Login / Signup

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.

Narges SeyfizadehDavid KalbermatterThomas ImhofMoritz RiesChristian MüllerLeonie JennerElisabeth BlumenscheinAlexandra YendrzheyevskiyFrank GrünKevin MoogDaniel EckertRonja EngelPhilipp DiebolderMohamed ChamiJürgen KraussTorsten SchallerMichaela Arndt
Published in: Journal of biomedical science (2024)
This biochemical and immunological study showcases the potential of an effective combination therapy with two monoclonal anti-gB IgGs for the treatment of HSV-1/2 induced disease conditions.
Keyphrases
  • combination therapy
  • herpes simplex virus
  • monoclonal antibody
  • high glucose
  • stem cells
  • drug induced
  • risk assessment
  • endothelial cells
  • replacement therapy
  • cell therapy